샘플 요청 목록

 카트 문의
시장보고서
상품코드
1526233

세계의 지속적 신대체요법(CRRT) 시장

Continuous Renal Replacement Therapy (CRRT)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 216 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

지속적 신대체요법(CRRT) 세계 시장은 2030년까지 23억 달러에 이를 전망

2023년에 15억 달러로 추정되는 지속적 신대체요법(CRRT) 세계 시장은 분석 기간인 2023-2030년에 CAGR 5.9%로 성장하여 2030년에는 23억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 투석액 및 교환액은 CAGR 5.4%를 나타내고, 분석 기간 종료시에는 15억 달러에 이를 것으로 예측됩니다. CRRT 일회용＆시스템 분야의 성장률은 분석 기간 CAGR로 6.9%로 추정됩니다.

미국 시장은 추정 3억 7,050만 달러, 중국은 CAGR 8.3%로 성장 예측

미국의 지속적 신대체요법(CRRT) 시장은 2023년에 3억 7,050만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023-2030년간 CAGR 8.3%로 성장을 지속하여, 2030년에는 3억 1,660만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.5%와 4.7%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.8%를 나타낼 전망입니다.

세계 지속적 신대체요법(CRRT) 시장 - 주요 동향 및 촉진요인 요약

지속적 신대체요법(CRRT)은 주로 중환자실(ICU)에서 급성 신부전 환자, 특히 혈역학적으로 불안정한 환자를 치료하는 데 사용되는 투석의 한 형태입니다. 몇 시간 동안 빠르게 용질과 수분을 제거하는 간헐적 혈액 투석과 달리, CRRT는 하루 24시간 동안 진행되어 신장의 원래 기능을 보다 충실하게 모방합니다. 이러한 점진적이고 지속적인 과정을 통해 노폐물과 과도한 수분을 점진적으로 제거할 수 있기 때문에 체액 상태가 불안정하고 신장 기능이 저하된 환자를 안정화시키는 데 도움이 되며, 특히 기존 투석에 수반되는 급격한 변화를 견딜 수 없는 중증 환자에서 체액과다 관리, 안정된 혈역학 및 혈액 화학적 조절에 특히 유용합니다. 급격한 변화를 견디지 못하는 중증 환자들에게 매우 중요합니다.

CRRT의 기술은 안전성, 효율성 및 다른 ICU 치료와의 통합성을 높이기 위해 크게 발전했습니다. 최신 CRRT 장비는 정밀한 체액 균형 제어, 정교한 사용자 인터페이스, 혈액 응고 및 저혈압과 같은 합병증 예방에 도움이 되는 통합 안전 기능을 갖추고 있습니다. 이러한 개선으로 인해 전 세계 ICU에서 CRRT의 도입이 증가했을 뿐만 아니라, 신장 기능 보조뿐만 아니라 패혈증 및 다발성 장기 부전에서의 혈액 정화 기술에도 적용이 확대되고 있습니다. 또한, 현재 진행 중인 멤브레인 기술과 투석액 혁신은 전해질 불균형 및 기타 부작용의 위험을 최소화하면서 용질 제거 효율을 높이도록 설계되었으며, 중환자실에서 CRRT와 다른 모니터링 및 치료 장비와의 통합은 중환자 치료에 대한 종합적인 접근 방식입니다. 복잡한 환자를 관리하기 위한 다각적인 전략을 뒷받침하는 종합적인 접근 방식입니다.

지속적 신장대체요법 시장의 성장은 급성신장병(AKI) 발생률 증가, CRRT 기술의 발전, CRRT의 장점에 대한 인식 증가, 세계 의료 인프라 확대 등 여러 요인에 의해 주도되고 있습니다. 인구 고령화와 당뇨병, 고혈압, 만성 신장 질환 등의 유병률 증가는 AKI 발생률 증가에 기여하고 CRRT에 대한 수요를 촉진하고 있으며, CRRT 장비의 효율성과 안전성을 향상시키는 기술 발전은 이 치료법을 보다 친숙하고 효과적으로 만들어 병원 전반에 걸쳐 광범위한 채택을 촉진하고 있습니다. 또한 의료 서비스 제공업체들이 중증 환자 관리의 뉘앙스에 대한 인식이 높아짐에 따라 기존 신장 대체 요법보다 CRRT의 이점이 강조되고 있으며, 이는 시장 성장에 기여하고 있습니다. 마지막으로, 특히 신흥국에서의 의료 인프라 확충은 CRRT와 같은 첨단 의료 기술을 채택할 수 있는 더 많은 기회를 제공하여 전체 시장 성장을 뒷받침하고 있습니다.

조사 대상 기업 예(주요 18개사)

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

LSH 24.08.09

Global Continuous Renal Replacement Therapy (CRRT) Market to Reach US$2.3 Billion by 2030

The global market for Continuous Renal Replacement Therapy (CRRT) estimated at US$1.5 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the CRRT Disposables & Systems segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$370.5 Million While China is Forecast to Grow at 8.3% CAGR

The Continuous Renal Replacement Therapy (CRRT) market in the U.S. is estimated at US$370.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$316.6 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Continuous Renal Replacement Therapy (CRRT) Market - Key Trends & Drivers Summarized

Continuous Renal Replacement Therapy (CRRT) is a form of dialysis used primarily in the intensive care unit (ICU) to treat acutely ill patients with renal failure, particularly when they are hemodynamically unstable. Unlike intermittent hemodialysis that rapidly removes solutes and fluids over a few hours, CRRT is performed over 24 hours a day, mimicking the kidneys’ natural functions more closely. This gentle and continuous process helps to stabilize patients with fluctuating fluid status and compromised kidney function by allowing for the gradual removal of waste products and excess fluid. CRRT is especially beneficial in managing fluid overload, maintaining stable hemodynamics, and controlling blood chemistry, which is crucial in critically ill patients who may not tolerate the rapid changes associated with conventional dialysis.

The technology behind CRRT has seen significant advancements aimed at enhancing safety, efficiency, and integration with other ICU therapies. Modern CRRT machines offer precise fluid balance control, sophisticated user interfaces, and integrated safety features that help prevent complications such as blood clotting and hypotension. These improvements have not only increased the adoption of CRRT in ICUs around the world but also expanded its applications beyond renal support to include blood purification techniques in sepsis and multi-organ failure. Moreover, ongoing innovations in membrane technology and dialysis solutions are designed to enhance solute removal efficiency while minimizing the risk of electrolyte imbalances and other side effects. The integration of CRRT with other monitoring and therapeutic devices in the ICU represents a comprehensive approach to critical care, supporting a multifaceted strategy for managing complex cases.

The growth in the Continuous Renal Replacement Therapy market is driven by several factors, including an increase in the incidence of acute kidney injury (AKI), advancements in CRRT technology, rising awareness of the therapy’s benefits, and expanding healthcare infrastructure globally. The aging population and higher prevalence of conditions such as diabetes, hypertension, and chronic kidney disease contribute to the rising incidence of AKI, thereby fueling the demand for CRRT. Technological advancements that enhance the efficiency and safety of CRRT machines make this treatment more accessible and effective, encouraging broader adoption across hospitals. Furthermore, as healthcare providers become more aware of the nuances of managing critically ill patients, there is a greater emphasis on the benefits of CRRT over traditional renal replacement therapies, which supports market growth. Lastly, the expansion of healthcare infrastructure, especially in emerging economies, provides additional opportunities for the adoption of advanced medical treatments like CRRT, supporting the overall growth of the market.

Select Competitors (Total 18 Featured) -

  • Toray Industries, Inc.
  • B. Braun Melsungen AG
  • Medtronic PLC
  • Baxter International, Inc.
  • B. Braun Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Nikkiso Co., Ltd.
  • Fresenius Medical Care AG & Co. KgaA
  • Asahi Kasei Medical Co., Ltd.
  • Medica SpA
  • NxStage Medical, Inc.
  • Nipro India Corporation Pvt., Ltd.
  • Xenios AG
  • Infomed SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Continuous Renal Replacement Therapy Market Set for a Steady Growth
    • Dialysates & Replacement Fluids Dominate the Market, Disposables to Register the Fastest Growth
    • Continuous Venovenous Hemofiltration (CVVH) Leads the Market, CVVHDF to Exhibit the Fastest Growth
    • Europe and US Hold the Largest Share, China to Witness Fastest Growth
    • Continuous Renal Replacement Therapy (CRRT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Future Endeavors in CRRT
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increase in Incidence of Acute Kidney Injury to Drive Market Growth
    • Rise in Aging Population, Growing Number of ICU Patients Spurs the Need for CRRT
    • Rising Incidence of Diabetes: A Key Risk Factor for Acute Kidney Failure
    • TABLE 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    • Increasing Incidence of Cardiovascular Disease Drive Market Growth
    • Prevalence of Heart Failure in Select Countries
    • Advancements in CRRT Machines: Designed for Reliable and Safe Treatment
    • Technological Advancements to Bolster Market Growth
    • Development of CRRT System for Pediatric Patients
    • Miniaturization and Wearable Technology Forays into Acute Renal Replacement Domain
    • Reimbursement Scenario
    • Development of New Hemofilters to Propel Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysates & Replacement Fluids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysates & Replacement Fluids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Disposables & Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Disposables & Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Continuous Venovenous Hemofiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Continuous Venovenous Hemofiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Continuous Venovenous Hemodialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Continuous Venovenous Hemodialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Continuous Venovenous Hemodiafiltration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Continuous Venovenous Hemodiafiltration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Slow Continuous Filtration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Slow Continuous Filtration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Continuous Renal Replacement Therapy (CRRT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Renal Replacement Therapy (CRRT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Product - Dialysates & Replacement Fluids and Disposables & Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Product - Percentage Breakdown of Value Sales for Dialysates & Replacement Fluids and Disposables & Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Continuous Renal Replacement Therapy (CRRT) by Modality - Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Continuous Renal Replacement Therapy (CRRT) by Modality - Percentage Breakdown of Value Sales for Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodialysis, Continuous Venovenous Hemodiafiltration and Slow Continuous Filtration for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제